June 2, 2026 2:42 pm

Tag: Crohn’s symptoms

New Hope for Severe Crohn’s: Breakthrough Drug Targets Scarring

Agomab Therapeutics has launched a groundbreaking clinical trial for ontunisertib, a drug specifically targeting fibrostenosing Crohn’s disease—the severe, scarring form that has limited treatment options. This represents the first targeted therapy designed to address the root cause of intestinal scarring rather than just managing symptoms.

You Missed

Week of May 11-17, 2026: Seven IBD research stories worth your attention

Week of May 11-17, 2026: Seven IBD research stories worth your attention

May 17, 2026
Coffee, Alcohol, and Carbonated Drinks in IBD Remission: My Experience

Coffee, Alcohol, and Carbonated Drinks in IBD Remission: My Experience

May 13, 2026
Week of May 4-10, 2026: 10 IBD research stories worth your attention

Week of May 4-10, 2026: 10 IBD research stories worth your attention

May 10, 2026
How I Self-Assess Whether a New Crohn's Drug Is Actually Working

How I Self-Assess Whether a New Crohn’s Drug Is Actually Working

May 7, 2026